Scientists hunt for genetic clues to breast cancer recurrence

NCT ID NCT00353483

Recruiting now Knowledge-focused Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to understand how breast cancer cells change after chemotherapy by comparing genetic markers before and after treatment. Researchers will collect blood, breast tissue, and bone marrow samples from 300 people with stage II to IV breast cancer. The goal is to find markers that predict if the cancer will come back, which could help doctors tailor future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify which genetic markers predict breast cancer recurrence, leading to more personalized treatments.
What could go wrong: This is an observational study, not a treatment trial. It may not directly benefit participants, and results may not change current care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST NEOPLASMS

Contacts and locations

Locations

Washington University School of Medicine
RECRUITING

St Louis, Missouri, 63119, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.